Daijiworld Media Network - Washington

Washington, Mar 3: Tens of thousands of Americans living with HIV are facing disruptions in treatment as nearly 20 states impose tighter restrictions on Ryan White AIDS Drug Assistance Programs (ADAPs), with several more considering similar measures, according to a report by health research group KFF.

ADAPs provide HIV medications, sometimes free, and cover insurance premiums for those in need. Interruptions in treatment can allow the virus to replicate, potentially creating drug-resistant strains and increasing the risk of new infections and AIDS cases.

Florida leads the changes, cutting off benefits for at least 16,000 residents, including coverage for Biktarvy, the most widely prescribed HIV drug. A special enrollment period opened by the Centers for Medicare & Medicaid Services allows affected residents to select new insurance plans through April 30.

ADAPs currently support roughly 25% of the 1.2 million people living with HIV in the U.S. Enrollment surged 30% from 2022 to 2024, partly due to pandemic-related Medicaid adjustments. Despite rising drug costs, federal funding has remained flat for over a decade, forcing states to adopt cost-cutting measures such as reducing covered medications or tightening income eligibility.

Experts warn that as more states implement work requirements and budget constraints, treatment interruptions could create wider public health and economic repercussions. Esteban Wood of the AIDS Healthcare Foundation described the situation as an “economic disaster, a public health disaster, a moral disaster,” with legal action underway to halt Florida’s restrictions.

The changes underscore growing concerns about access to life-saving HIV care amid rising costs and limited federal support, leaving vulnerable populations at increased risk.